loading
前日終値:
$2.69
開ける:
$2.71
24時間の取引高:
1.43M
Relative Volume:
0.38
時価総額:
$555.97M
収益:
$12.87M
当期純損益:
$-114.34M
株価収益率:
-2.9956
EPS:
-0.8646
ネットキャッシュフロー:
$-79.23M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+9.28%
6か月 パフォーマンス:
+70.39%
1年 パフォーマンス:
+15.62%
1日の値動き範囲:
Value
$2.575
$2.72
1週間の範囲:
Value
$2.34
$2.745
52週間の値動き範囲:
Value
$1.05
$3.31

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
名前
Taysha Gene Therapies Inc
Name
セクター
Healthcare (1161)
Name
電話
(214) 612-0000
Name
住所
3000 PEGASUS PARK DRIVE, DALLAS
Name
職員
73
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
TSHA's Discussions on Twitter

TSHA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
2.59 687.82M 12.87M -114.34M -79.23M -0.8646
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-11 開始されました BofA Securities Buy
2024-06-27 開始されました BMO Capital Markets Outperform
2024-04-09 開始されました Piper Sandler Overweight
2023-02-01 ダウングレード Jefferies Buy → Hold
2023-01-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-11-09 ダウングレード Goldman Buy → Neutral
2022-03-09 開始されました Robert W. Baird Outperform
2022-03-01 開始されました Wells Fargo Overweight
2022-02-18 開始されました SMBC Nikko Outperform
2021-12-16 開始されました Guggenheim Buy
2021-07-16 開始されました Needham Buy
2021-06-24 開始されました Truist Buy
2021-06-15 開始されました BTIG Research Buy
2021-06-09 開始されました Wedbush Outperform
2021-06-08 開始されました JMP Securities Mkt Outperform
2021-05-19 開始されました Cantor Fitzgerald Overweight
2021-05-11 再開されました Jefferies Buy
2021-02-24 開始されました William Blair Outperform
2021-01-05 開始されました Oppenheimer Outperform
2020-10-19 開始されました Chardan Capital Markets Buy
2020-10-19 開始されました Goldman Buy
2020-10-19 開始されました Jefferies Buy
2020-10-19 開始されました Morgan Stanley Overweight
すべてを表示

Taysha Gene Therapies Inc (TSHA) 最新ニュース

pulisher
Jul 24, 2025

Can Taysha Gene Therapies Inc. stock recover from recent declineConsistently profitable trades - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Taysha Gene Therapies Inc. stockGame-changing capital returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Rett bet set includes Neurogene, Taysha gene therapies - BioWorld MedTech

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Taysha Gene Therapies Inc. stock priceUnrivaled growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Taysha Gene Therapies Inc. Stock Analysis and ForecastFree AI-Backed Trading Signals - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Taysha Gene Therapies Inc. a good long term investmentHigh-impact investment strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 17, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $8.17 Consensus PT from Analysts - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Jul 16, 2025
pulisher
Jul 15, 2025

Why Taysha Gene Therapies Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Taysha Gene Therapies Inc. stock price move sharplyFree Long-Term Wealth Growth Plan - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Taysha Gene Therapies Inc. stock performs during market volatilityFree Popular Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

How did TSHA's Q1 2024 EPS surprise impact short-term traders? - AInvest

Jul 13, 2025
pulisher
Jul 13, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Coverage Initiated at Bank of America - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

Biotech Bargains: Finding Gold in the Healthcare Sell-Off - AInvest

Jul 12, 2025
pulisher
Jul 11, 2025

Taysha Gene's 5.9% Surge: A Deep Dive into the Unexplained Rally - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

BofA Securities initiates coverage on Taysha Gene Therapies stock with Buy rating - Investing.com Canada

Jul 11, 2025
pulisher
Jul 11, 2025

BofA Assigns Buy Rating to Taysha Gene Therapies (TSHA) with $8 Target | TSHA Stock News - GuruFocus

Jul 11, 2025
pulisher
Jul 10, 2025

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - MSN

Jul 10, 2025
pulisher
Jul 08, 2025

Goldman Sachs Group Inc's Strategic Acquisition in Taysha Gene Therapies Inc - GuruFocus

Jul 08, 2025
pulisher
Jul 03, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus

Jul 03, 2025
pulisher
Jul 03, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025
pulisher
Jul 03, 2025

Taysha Gene Therapies (TSHA) Gets a Buy from Wells Fargo - The Globe and Mail

Jul 03, 2025
pulisher
Jul 01, 2025

Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock - Nasdaq

Jul 01, 2025
pulisher
Jul 01, 2025

Taysha Gene Therapies (TSHA) Receives Buy Rating from Needham | - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

Taysha Gene Therapies (TSHA) Receives Buy Rating from Needham | TSHA Stock News - GuruFocus

Jul 01, 2025
pulisher
Jun 30, 2025

Cantor Fitzgerald Reiterates “Overweight” Rating on Taysha (TSHA) for Positive TSHA-102 Clinical Data - MSN

Jun 30, 2025
pulisher
Jun 25, 2025

Rhumbline Advisers Boosts Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 25, 2025
pulisher
Jun 24, 2025

Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT - Yahoo Finance

Jun 24, 2025
pulisher
Jun 22, 2025

Taysha Gene Therapies, Inc.(NasdaqGS:TSHA) added to S&P Biotechnology Select Industry Index - MarketScreener

Jun 22, 2025
pulisher
Jun 14, 2025

Taysha Gene Therapies’ SWOT analysis: promising Rett syndrome therapy boosts stock outlook - Investing.com Australia

Jun 14, 2025

Taysha Gene Therapies Inc (TSHA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):